In particular, they increase PD-L1 expression in several cancer models including hepatocellular carcinoma, anaplastic thyroid cancer and melanoma (Woods et al. 2015; Llopiz et al. 2019; Hegedűs et al. 2020). Here, CD274 is linked to hepatocellular carcinoma.